Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'
Br J Cancer
.
2018 Feb 6;118(3):e1.
doi: 10.1038/bjc.2017.342.
Epub 2017 Nov 16.
Author
Isabel Bravo
1
Affiliation
1
Medical Physics and Radiobiology Group, IPO Porto Research Centre, Portuguese Oncology Institute of Porto, Porto 4200-072, Portugal.
PMID:
29149108
PMCID:
PMC5808019
DOI:
10.1038/bjc.2017.342
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Male
Neoplasm Recurrence, Local / radiotherapy
Prostatic Neoplasms / radiotherapy*
Radiosurgery*